Anthony Johnson

Company: Goldfinch Bio

Job title: President & Chief Executive Officer

Seminars:

Panel Discussion: Challenges & Opportunities in Drug Development for Rare Kidney Diseases 4:00 pm

Precision medicine in rare kidney disease drug development Strategies in selecting endpoints for regulatory approval Partnering with patient advocacy groups and registriesRead more

day: Day One

Leveraging a Precision Medicine Approach to Inform Future Directions of Drug Development in CKD 11:30 am

Reflecting on recent progress: what has been achieved so far? Applying lessons in biomarkers and clinical trial innovation to CKD drug development Looking to the future: paving the way for pipeline progression and new therapiesRead more

day: Track 2 - Day 1 AM